Thalassemia Intermedia
Information
- Disease name
- Thalassemia Intermedia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01140321 | Completed | Phase 2 | Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI | January 2004 | May 2010 |
| NCT01224496 | Completed | Phase 1/Phase 2 | Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders | July 2009 | August 2011 |
| NCT01496963 | Completed | Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia | January 2012 | December 2021 | |
| NCT05444894 | Recruiting | Phase 1/Phase 2 | EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) | April 29, 2022 | December 2025 |
| NCT06137079 | Recruiting | "Iron Overload and Endocrinological Diseases" | June 20, 2013 | December 31, 2025 | |
| NCT01624038 | Unknown status | Phase 2/Phase 3 | Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin. | June 2012 | December 2012 |